U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07311356) titled 'Prognosis of Early-onset Anorexia Nervosa' on Dec. 16.
Brief Summary: The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.
Study Start Date: Dec. 20
Study Type: OBSERVATIONAL
...